FindTrial
Sign In

Survival in multicentric glioma

Outcomes for patients with diffuse glioma having multicentric or multifocal disease - Glio-MM

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/053333
Enrollment
500
Registered
2023-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C719- Malignant neoplasm of brain, unspecified

Interventions

Intervention1: Not Applicable: Not Applicable Control Intervention1: Not Applicable: Not Applicable

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Adults ( >18 years) with multicentric or multifocal diffuse gliomas identified in TMC between January 2010 and December 2022.

Exclusion criteria

Exclusion criteria: 1. Circumscribed gliomas 2. Pediatric gliomas 3. Absence of tissue diagnosis

Design outcomes

Primary

MeasureTime frame
1. Clinical characteristics (patient, disease, treatment-related) in patients with MC & MF gliomas. 2. Survival outcomes of MC & MF gliomas.Timepoint: After study completion—

Secondary

MeasureTime frame
Influence of clinical features on survival outcomes.Timepoint: after completion of the study—

Countries

India

Contacts

Public ContactDr Archya Dasgupta

Tata Memorial Centre

archya1010@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026